Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Sep 16;22(1):4–10. doi: 10.1016/j.bbmt.2015.09.001

Table 2.

Confidence Levels

Pathologic evidence Clinician assessment Treatment for acute GVHD Comments
Confirmed Unequivocal pathologic evidence of GVHD GVHD is the etiology for symptoms Not applicable GVHD is clearly present even if other etiologies may co-exist simultaneously
Probable Not required GVHD most likely etiology for symptoms (as evidenced by treatment being provided) Yes GVHD is most likely present but other etiologies may also explain the symptoms and there insufficient evidence to make a confirmed diagnosis
Possible Not required GVHD in differential diagnosis (but no treatment is being provided) No GVHD may be present, but other etiologies are favored to the degree that GVHD treatment is not initiated
Negative Unequivocal evidence of a diagnosis other than GVHD (e.g., drug rash) GVHD is not considered as an explanation for the symptoms No and the symptoms resolve without GVHD treatment A “negative” biopsy (e.g., normal skin) is not unequivocal evidence of a diagnosis other than GVHD